Le Lézard
Classified in: Health
Subject: PLW

Holganix Receives US Patent for Microbial Bionematicide Technology

Holganix was granted a patent for microbial bionematicide technology that is environmentally friendly and shown to reduce plant parasitic nematodes by over 75% in preliminary studies.

ASTON, Pa., Oct. 13, 2022 /PRNewswire-PRWeb/ -- Holganix is an agricultural biotechnology company that develops microbial products used by farmers to increase yields, boost soil health, and reduce fertilizer requirements. Today Holganix announced it has been granted a US patent (US 11,447,427 B2) for a new microbial bionematicide technology. While studies are still ongoing, preliminary results have shown a 75% reduction in plant parasitic nematodes in a lab setting and an 80% reduction in a field setting.

The new bionematicide harnesses the power of soil microbes to reduce plant parasitic nematodes including soybean cyst, corn lesion, tomato root-knot, lance, and sting nematodes. The technology utilizes three modes of action: (1) it affects the migration of nematodes to the roots, (2) it inhibits eggs from hatching, and (3) it targets plant parasitic nematodes. The new bionematicide technology is still in development and is not yet commercialized or registered with the EPA.

"With these encouraging preliminary results and intellectual property, Holganix is positioned to develop a truly unique bionematicide product for the agriculture and turf industries," explains Holganix President of Agriculture, David Stark, Ph.D. "Nematodes represent a $100 billion problem in terms of worldwide plant loss, and current solutions are often harmful to the soil and the environment. Because Holganix's technology revolves around the use of a naturally occurring, concentrated, and stabilized stack of soil microbes, this bionematicide technology will be friendly for the environment."

The patent (patent number: US 11,447,427 B2), entitled "Methods For Controlling Pathogenic Plant Nematodes and For Improving the Health and/or Performance of Ruminant Animals," was awarded to inventors, David Stark, Ph.D., President of Agriculture at Holganix LLC and Robert Neidermyer, Ph.D., Director of Soil Health at Holganix LLC.

"We are excited that the patent agency granted protection for our novel, microbial bionematicide technology and are looking forward to continuing to develop the product, registering the product through the EPA, and commercializing it for agricultural, turf, and ornamental use," explains Stark.

About Holganix:
Holganix is a manufacturer of microbial products that harness the power of soil microbes to build soil health, improve crop yield, and reduce the need for fertilizer. Holganix products allow farmers to improve their profit per acre, giving farmers the tools they need to drive both economic and environmental sustainability on the farm.

Media Contact

Kaitlyn Ersek, Holganix LLC, 1 866-563-2784, [email protected]




These press releases may also interest you

at 21:15
The National Health IT Collaborative for the Underserved (NHIT), the first and oldest national non-profit focused on equitable access to health technology for underserved communities and communities of color, celebrated its 15th anniversary today...

at 21:00
The "Social Anxiety Disorder (SAD) - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The Social Anxiety Disorder (SAD) market report provides current treatment practices, emerging...

at 20:45
The "Global Continuous Glucose Monitoring Solutions Market, 2027 Forecast" report has been added to  ResearchAndMarkets.com's offering. Technological advancements and strategic partnerships create new opportunities for CGM vendors. The rising...

at 20:40
Researchers at Kanazawa University report in ACS Nano how ultrathin layers of tin disulfide can be used to accelerate the chemical reduction of carbon dioxide - a finding that is highly relevant for our quest towards a carbon-neutral society....

at 20:15
The "Regenerative Medicines: Bone and Joint Applications" report has been added to  ResearchAndMarkets.com's offering. The global market for regenerative medicine for bone and joint applications was valued at $9.6 billion in 2022. By technology, this...

at 20:10
The Canadian Animal Health Institute is thrilled to announce the winners of the inaugural ?Cutest Pets on Parliament Hill Contest'. Parliamentarians, Senators, staffers, and members of the Press Gallery on Parliament Hill, submitted more than 65...

News published on and distributed by: